Recurrent hyperkalemia in patients with chronic kidney disease and hepatitis C treated with direct antiviral agents

Sofosbuvir is the keystone of direct antiviral agents for the chronic hepatitis C (CHC). The safety of sofosbuvir in patients with stage 4 –5 chronic kidney disease (CKD) needs further observation in real world.

Source: BMC Infectious Diseases - June 21, 2019 Category: Infectious Diseases Authors: Taotao Yan, Jiuping Wang, Juan Li, Shan Fu, Yi Chen, Chunhua Hu, Rou Zhang, Zhen Tian, Fahui Zhao, Jun Dong, Jinfeng Liu, Yuan Yang, Tianyan Chen, Yingren Zhao and Yingli He Tags: Case report Source Type: research